K. Chiller et al., Efficacy of curettage before excision in clearing surgical margins of nonmelanoma skin cancer, ARCH DERMAT, 136(11), 2000, pp. 1327-1332
Objective: To determine whether curettage before excision of basal cell car
cinoma (BCC) and squamous cell carcinoma (SCC) improves margin clearance ra
tes.
Design: A retrospective, nonrandomized, case-control series of nonmelanoma
skin cancers treated with preexcisional curettage followed by simple excisi
on was identified using a computerized search of the database of a dermatop
athology service. A validation cohort was established by manually identifyi
ng nonmelanoma skin cancers treated with wide excision on a given day.
Setting: All analyzed specimens were derived from the Dermatopathology Serv
ice at the University of California, San Francisco, a university-based labo
ratory that provides interpretation of skin biopsy specimens received direc
tly from community (90%) and academic (10%) practices.
Patients: Our retrospective cohort consisted of all nonrecurrent nonmelanom
a skin cancers diagnosed by biopsy and treated by simple excision between A
pril 1, 1997, and April 30, 1999. There were 1983 BCCs and 849 SCCs include
d in our study. The validation cohort included skin cancers diagnosed by bi
opsy treated with simple excision on the 16th day of each month during the
same period.
Intervention: Preexcisional curettage.
Main Outcome Measure: We compared the frequency of tumor margin involvement
of curetted vs noncuretted lesions. Margin involvement was considered surg
ical failure.
Results: Forty-two percent of BCCs and 34% of SCCs were curetted before exc
ision. In BCC, risks for surgical failure included head and neck lesions (P
<.001), lesions treated by physicians performing fewer than 51 procedures (
P<.001), and invasive subtypes (P<.01). Factors associated with surgical fa
ilure in SCC included in situ disease (P=.01) and an older (77 vs 74 years)
patient population (P=.05). In univariate analysis, curettage before excis
ion decreased the surgical failure rate for BCC by 24% (P=.03) but did not
decrease the rate for SCC (P=.8). In multivariate analysis, curettage of BC
C reduced surgical failure rates by 26% when the physician performed 50 ski
n cancer excisions or less during the study (odds ratio, 0.74; 95% confiden
ce interval, 0.57-0.95; P=.02).
Conclusion: Preoperative curettage decreases the frequency of positive marg
ins in the management of BCC but not of SCC.